Company History

2024

  • February

    Escitalopram receives approval in Japan

  • June

    Selected as one of the 1,000+ global powerhouses

  • August

    Ibandronate receives approval in Japan

2022

2020

  • June

    Selected as a global powerhouse

  • October

    Selected as Jeju local small and
    medium-sized enterprise

2018

2017

  • July

    Establishment of BRIO PHARMA,
    a Japanese corporation

  • September

    Selected for the high-growth company export capacity enhancement project

  • December

    Awarded Export Award at the 6th Jeju
    Exporter's Day

2016

2014

  • October

    Moved into new office building
    (Hawon-dong) in Seogwipo-si, Jeju-do

  • January

    Headquarters moved to Seogwipo-si,
    Jeju-do (Beophwan-dong)

2013

2011

  • June

    Awarded the $20 million Export Tower Award at the 48th Trade Day

  • November

    Received the $10 million Export Tower Award at the 47th Trade Day

2010

2009

  • September

    OHSONG PHARM Co., Ltd. established